Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes
- PMID: 23213275
- PMCID: PMC3513186
Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes
Abstract
Purpose: Chronic hyperglycemia and hypoxemia are believed to be causal factors in the development of proliferative diabetic retinopathy (PDR) among individuals with type 2 diabetes. It is hypothesized that formation of new blood vessels in the retina due to prolonged hypoxia is associated with increased expression of several growth factors and angiogenic cytokines. In the present study, we investigated the association of genetic polymorphisms in vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-β), and interferon γ (IFN-γ) genes, which may be responsible for the hypoxia-induced VEGF-mediated neovascularization pathway for the pathogenesis of PDR.
Methods: Our case-control association study composed of 493 ethnically matched volunteers (253 with PDR [cases] and 240 diabetic controls [DC]). Gene polymorphisms were determined with Taqman-based real-time PCR and amplification refractory mutation analysis system PCR.
Results: The VEGF-460C (rs833061C; p=0.0043) and IFN-γ +874T (rs2430561T; p=0.0011) alleles were significantly associated with PDR.
Conclusions: Genetic variations at VEGF-460C and IFN-γ +874T might accelerate the pathogenesis of retinal neovascularization in PDR.
Similar articles
-
Vascular endothelial growth factor (VEGF)-related polymorphisms rs10738760 and rs6921438 are not risk factors for proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus (T2DM).Bosn J Basic Med Sci. 2019 Feb 12;19(1):94-100. doi: 10.17305/bjbms.2018.3519. Bosn J Basic Med Sci. 2019. PMID: 30579324 Free PMC article.
-
Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.Mol Vis. 2018 May 18;24:394-406. eCollection 2018. Mol Vis. 2018. PMID: 29853773 Free PMC article.
-
The relationships between type 2 diabetic retinopathy and VEGF-634G/C and VEGF-460C/T polymorphisms in Han Chinese subjects.J Diabetes Complications. 2014 Nov-Dec;28(6):785-90. doi: 10.1016/j.jdiacomp.2014.08.003. Epub 2014 Aug 16. J Diabetes Complications. 2014. PMID: 25217793
-
Associations between Vascular Endothelial Growth Factor Gene Polymorphisms and Different Types of Diabetic Retinopathy Susceptibility: A Systematic Review and Meta-Analysis.J Diabetes Res. 2021 Jan 4;2021:7059139. doi: 10.1155/2021/7059139. eCollection 2021. J Diabetes Res. 2021. PMID: 33490285 Free PMC article.
-
Candidate genes for proliferative diabetic retinopathy.Biomed Res Int. 2013;2013:540416. doi: 10.1155/2013/540416. Epub 2013 Aug 27. Biomed Res Int. 2013. PMID: 24066292 Free PMC article. Review.
Cited by
-
Association of VEGF gene polymorphisms with diabetic retinopathy: a meta-analysis.PLoS One. 2013 Dec 20;8(12):e84069. doi: 10.1371/journal.pone.0084069. eCollection 2013. PLoS One. 2013. PMID: 24376787 Free PMC article.
-
Apelin-13 induces proliferation, migration, and collagen I mRNA expression in human RPE cells via PI3K/Akt and MEK/Erk signaling pathways.Mol Vis. 2013 Nov 7;19:2227-36. eCollection 2013. Mol Vis. 2013. PMID: 24227918 Free PMC article.
-
Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.Exp Eye Res. 2014 Aug;125:79-88. doi: 10.1016/j.exer.2014.05.012. Epub 2014 Jun 6. Exp Eye Res. 2014. PMID: 24910902 Free PMC article.
-
Association between diabetic retinopathy and polymorphisms of cytokine genes: a systematic review and meta-analysis.Int Ophthalmol. 2022 Jan;42(1):349-361. doi: 10.1007/s10792-021-02011-9. Epub 2021 Aug 25. Int Ophthalmol. 2022. PMID: 34432176
-
Tocotrienol-rich fraction reduces retinal inflammation and angiogenesis in rats with streptozotocin-induced diabetes.BMC Complement Med Ther. 2023 Jun 2;23(1):179. doi: 10.1186/s12906-023-04005-9. BMC Complement Med Ther. 2023. PMID: 37268913 Free PMC article.
References
-
- Abu EA, Ahmed M. Al-Mezaine, Hani S, Ola MS. Pathophysiology and management of diabetic ratinopathy. Expert Rev Ophthalmol. 2009;4:627–47.
-
- Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102:527–32. - PubMed
-
- Linsenmeier RA, Braun RD, McRipley MA, Padnick LB, Ahmed J, Hatchell DL, McLeod DS, Lutty GA. Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci. 1998;39:1647–57. - PubMed
-
- Zhang W, Ito Y, Berlin E, Roberts R, Berkowitz BA. Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2003;44:3119–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical